The Pancreatic Cancer market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Pancreatic Cancer: An Overview
Pancreatic adenocarcinoma is one of the most aggressive forms of cancer and is projected to arise as the second leading cause of cancer-related deaths in Europe and the United States in the near future. In the US, pancreatic cancer is the 9th or 10th most commonly diagnosed cancer (depending on gender).
Pancreatic cancer is advanced when it is unresectable, or cannot be removed by surgery. Cancer has spread to nearby blood vessels or lymph nodes, somewhat outside the pancreas or to distant organs (metastasis). Approximately 45% to 55% of patients are diagnosed with this stage.
Pancreatic Cancer Market Key Facts
-
Pancreatic cancer is typically characterized by its aggressive tumour growth and dismal prognosis. Each year more than 50,000 people in the United States (and double this number in Europe) are now diagnosed with pancreatic cancer (adenocarcinoma). Approximately 30% of patients with pancreatic cancer present with locally advanced disease.
-
As per the study conducted by Ilic et al. titled “Epidemiology of pancreatic cancer”, mortality of pancreatic cancer in both genders increases with age, and almost 90% of all deaths are registered after the age of 55 years. The highest mortality rates in 2012 in males were recorded in Central and Eastern Europe.
-
As per DelveInsight, males are more commonly affected in the case of Pancreatic Cancer than females.
The pancreatic Cancer market size is expected to change in the coming years owing to the rise in the number of incident cases in the 7MM.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Pancreatic Cancer market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Pancreatic Cancer market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Pancreatic Cancer Epidemiology
The epidemiology section covers insights about the historical and current Pancreatic Cancer patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Pancreatic Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pancreatic Cancer market or expected to get launched in the market during the study period. The analysis covers Pancreatic Cancer market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Pancreatic Cancer Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Get the PDF Sample of the Report:- https://www.delveinsight.com/sample-request/pancreatic-cancer-market
Pancreatic Cancer Therapeutics Analysis
At present several key players are developing therapies in the Pancreatic Cancer market. In the coming years owing to the positive outcomes of the emerging pipeline candidates the dynamics of the Pancreatic Cancer market is expected to transform.
Pancreatic Cancer Therapies covered in the report include:
-
EndoTAG-1
-
Masitinib
-
AZD6738
-
NanoPac
-
CPI-613
-
GC4419
-
Pamrevlumab
-
PD-L1 t-hank and N-803
And many more
Some of the key companies in the Pancreatic Cancer Market include:
-
Merck
-
Eli Lily
-
FibroGen
-
AB Science
-
NanOlogy
-
AstraZeneca
-
OSI Pharmaceuticals
-
NantKwest
-
ImmunityBio
-
Rafael Pharmaceuticals
-
Galera Therapeutics
-
SynCore Biotechnology
-
BioXcel Therapeutics
And others
Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/pancreatic-cancer-market
Table of Content
1. Key Insights
2. Executive Summary
3. Pancreatic Cancer Competitive Intelligence Analysis
4. Pancreatic Cancer Market Overview at a Glance
5. Pancreatic Cancer Disease Background and Overview
6. Pancreatic Cancer Patient Journey
7. Pancreatic Cancer Epidemiology and Patient Population
8. Pancreatic Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Pancreatic Cancer Unmet Needs
10. Key Endpoints of Pancreatic Cancer Treatment
11. Pancreatic Cancer Marketed Products
12. Pancreatic Cancer Emerging Therapies
13. Pancreatic Cancer Seven Major Market Analysis
14. Attribute Analysis
15. Pancreatic Cancer Market Outlook (7 major markets)
16. Pancreatic Cancer Access and Reimbursement Overview
17. KOL Views on the Pancreatic Cancer Market.
18. Pancreatic Cancer Market Drivers
19. Pancreatic Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/pancreatic-cancer-market
Other Latest Reports By DelveInsight
Asthma Diagnostic Devices Market
DelveInsight’s “Asthma Diagnostic Devices Market” report delivers an in-depth understanding of Asthma Diagnostic Devices, the historical and forecasted Asthma Diagnostic Devices market size, share, trends in North America, Europe, APAC, and RoW, as well as the emerging devices and key companies operating in the domain.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/